Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Read more in #EHJ
#CardioTwitter European Society of Cardiology European Society of Cardiology Journals #metaanalysis Professor Vijay Kunadian
academic.oup.com/eurheartj/adva…

⚡️Just published⚡️
❤️‍🔥Cardiovascular disease lead cause of mortality in older adults
❤️‍🔥Read here our individual patient meta-analysis from Italy, Spain, UK, Norway, Sweden-invasive vs conservative care of NSTEACS in older adults Geir Hirlekar Abdulla A. Damluji, MD, PhD
academic.oup.com/eurheartj/adva…

5 points from associated editorial by my friend and colleague Professor Vijay Kunadian on FULL REVASC: NEJM

🥸Summary

👇👇👇

Original Article: FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction (FULL REVASC) nej.md/3xj5b7u

Editorial: Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome nej.md/3PPZQLo

American College of Cardiology #ACC24

Is coronary slow-flow a reliable angiographic surrogate for wire-based physiology testing in INOCA? To be presented at #ACC24 and published simultaneously: ahajournals.org/doi/10.1161/CI… Nathaniel Smilowitz Anais Hausvater #AHAJournals

Presented at #ACC24 :

FULL REVASC: In a registry-based trial, FFR-guided PCI of nonculprit lesions did not result in a lower risk of a composite of death from any cause, myocardial infarction, or unplanned revascularization than culprit-lesion-only PCI. nej.md/3xj5b7u

#ACC2024
#FULLREVASC trial
💥In ACS and multivessel disease, Culprit only PCI vs. FFR guided non-culprit PCI
💥Read my editorial ⬇️ on how this trial impacts clinical practice NEJM

FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction | New England Journal of Medicine nejm.org/doi/full/10.10…

Role of Physiology in the Management of Nonculprit Lesions in Acute Coronary Syndrome | New England Journal of Medicine #ACC2024 nejm.org/doi/full/10.10…

A long-waited PREVENT trial is now presented at LBCT-V #ACC2024
🇰🇷From the inception of trial to completion of trial took a decade.
✅1,606 pts with intracoronary imaging-detected “Vulnerable Plaque” randomized 1:1 to (1) Preventive PCI vs (2) OMT alone.
✅Prevent PCI…

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial - The Lancet thelancet.com/journals/lance…

Transcatheter or Surgical Treatment of Aortic-Valve Stenosis | New England Journal of Medicine nejm.org/doi/full/10.10…

Presented today at #ACC24 :

A randomized trial that enrolled patients with severe aortic stenosis at low or intermediate surgical risk showed that TAVI was noninferior to SAVR at 1 year. Read the full DEDICATE-DZHK6 trial results: nej.md/3TLx8MT

In the SMART trial of TAVR in patients with a small aortic annulus, a self-expanding valve was noninferior to a balloon-expandable valve for clinical outcomes and was superior for bioprosthetic-valve dysfunction through 12 months. Full results: nej.md/49p7VO7

#ACC24

Original Article: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes (STEP-HFpEF DM) nej.md/3TPKpUC

American College of Cardiology #ACC24

Role of coronary computed tomography angiography to optimise percutaneous coronary intervention outcomes

heart.bmj.com/content/early/…

Professor Vijay Kunadian American College of Cardiology Dipti Itchhaporia, M.D., MACC , FAHA, FESC So wonderful to see you and learn about all the work you are doing, Vijay! You are an inspiration for all of us ICs.. Goodluck with all your endeavors 😉! #ACC24 #ACCWIC #ACCIC SCAIWIN American College of Cardiology

#ACC2024
Great also to catch up with so many friends in addition to outstanding science! American College of Cardiology Dipti Itchhaporia, M.D., MACC , FAHA, FESC Poonam Velagapudi

#ACC2024
When in Atlanta, absolute pleasure to stop by and say hello to Emory University School of Medicine Professor Nanette Wenger pioneering woman in cardiology! An absolute legend❤️
Had the pleasure to work with her on our European Society of Cardiology 2023 ACS guidelines task force.

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | New England Journal of Medicine nejm.org/doi/full/10.10…